Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Ligand Pharmaceuticals
Business Segments
Products & Services
Gross contract asset
Gross contract asset
Ligand Pharmaceuticals
·
Products & Services
·
1 segment
·
Rolls up to
Contract Assets
Breakdown
Segments
Phase 3 clinical trial
View metric
Quarterly
Annual
TTM
Segment
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Phase 3 clinical trial
$10M
$10M
$10M
$10M
$10M
$10M
$10M
$10M
Total
—
—
—
—
—
—
—
—